Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases

Schick, Ulricke; Jorcano, Sandra; Nouet, Philippe; Rouzaud, Michel; Vees, Hansjoerg; Zilli, Thomas; Ratib, Osman; Weber, Damien; Miralbell, Raymond

doi:10.3109/0284186X.2013.764010

Scientific article

English

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases

ContributorsSchick, Ulricke; Jorcano, Sandra; Nouet, Philippe; Rouzaud, Michel; Vees, Hansjoerg; Zilli, Thomas; Ratib, Osman; Weber, Damien; Miralbell, Raymond

Published inActa oncologica, vol. 52, no. 8, p. 1622-1628

Publication date2013

Abstract

Substantial survival may be observed with oligometastatic prostate cancer. Combining androgen deprivation (AD) and high-dose external beam radiotherapy (RT) to isolated regional or distant lesions may be proposed for these patients and the outcome of this strategy is the purpose of the present report.

Keywords

Aged
Aged, 80 and over
Androgen Antagonists/therapeutic use
Chemoradiotherapy
Dose-Response Relationship, Radiation
Follow-Up Studies
Humans
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Metastasis
Neoplasm Recurrence, Local/mortality/pathology/therapy
Neoplasm Staging
Positron-Emission Tomography
Prognosis
Prostatic Neoplasms/mortality/pathology/therapy
Radiopharmaceuticals/diagnostic use
Radiotherapy, Conformal
Survival Rate
Tomography, X-Ray Computed

Affiliation

Faculté de médecine / Section de médecine clinique / Département de radiologie et informatique médicale

Research group

Citation (ISO format)

SCHICK, Ulricke et al. Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases. In: Acta oncologica, 2013, vol. 52, n° 8, p. 1622–1628. doi: 10.3109/0284186X.2013.764010

Article (Published version)

Identifiers

PID : unige:44320
DOI : 10.3109/0284186X.2013.764010
PMID : 23544357

ISSN of the journal0284-186X

525views

0downloads

Creation12/22/2014 3:34:00 PM

First validation12/22/2014 3:34:00 PM

Update time03/14/2023 10:33:33 PM

Status update03/14/2023 10:33:33 PM

Last indexation08/29/2023 1:54:51 PM

Archive ouverte UNIGE

Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases

Technical informations